Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
暂无分享,去创建一个
R. Brandes | S. Devaraj | Xiangling Chen | K. Schröder | C. Szyndralewiez | Joy X Jiang | P. Page | N. Török | N. Serizawa | Joy X. Jiang
[1] Min Zhang,et al. Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase , 2012, Circulation research.
[2] Sophie Houngninou-Molango,et al. Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors. , 2011, Bioorganic & medicinal chemistry.
[3] Natalie J Torok,et al. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation , 2011, Hepatology.
[4] Y. Gorin,et al. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. , 2011, Kidney international.
[5] K. Iwaisako,et al. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice , 2011, Hepatology.
[6] A. Shah,et al. Control of Hepatic Nuclear Superoxide Production by Glucose 6-Phosphate Dehydrogenase and NADPH Oxidase-4* , 2011, The Journal of Biological Chemistry.
[7] Sophie Houngninou-Molango,et al. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. , 2010, Journal of medicinal chemistry.
[8] S. Friedman,et al. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. , 2010, Gastroenterology.
[9] W. Mehal,et al. Cell death and fibrogenesis. , 2010, Seminars in liver disease.
[10] J. Lambeth,et al. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection , 2010, Hepatology.
[11] M. Mohamadnejad,et al. Adenosine inhibits chemotaxis and induces hepatocyte‐specific genes in bone marrow mesenchymal stem cells , 2010, Hepatology.
[12] Joy X Jiang,et al. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. , 2009, Journal of hepatology.
[13] F. Martinez,et al. NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury , 2009, Nature Medicine.
[14] I. Fabregat,et al. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. , 2009, Biochimica et biophysica acta.
[15] I. Fabregat,et al. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. , 2008, Journal of hepatology.
[16] A. Diehl,et al. Mechanisms of disease progression in nonalcoholic fatty liver disease. , 2008, Seminars in liver disease.
[17] R. Urtasun,et al. Oxidative and nitrosative stress and fibrogenic response. , 2008, Clinics in liver disease.
[18] R. Schwabe,et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. , 2007, Gastroenterology.
[19] G. Gores,et al. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas‐induced murine liver injury by altering Bcl‐2 proteins , 2006, Hepatology.
[20] Natalie J Torok,et al. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo , 2006, Hepatology.
[21] D. Häussinger,et al. Involvement of NADPH Oxidase Isoforms and Src Family Kinases in CD95-dependent Hepatocyte Apoptosis* , 2005, Journal of Biological Chemistry.
[22] S. Friedman,et al. Cytochrome P450 2E1-derived Reactive Oxygen Species Mediate Paracrine Stimulation of Collagen I Protein Synthesis by Hepatic Stellate Cells* , 2002, The Journal of Biological Chemistry.
[23] G. Gores,et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. , 2000, The Journal of clinical investigation.
[24] T. Niki,et al. Purification of rat hepatic stellate cells by side scatter–activated cell sorting , 1998, Hepatology.
[25] J. Iredale,et al. Pathogenesis of liver fibrosis. , 1997, Clinical science.
[26] P. Bioulac-Sage,et al. [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.